How the Narrative Around Quest Diagnostics Is Evolving After Recent Results and Analyst Updates

Quest Diagnostics' fair value estimate remains steady at $197.25 per share, with only a slight uptick in the discount rate. This reflects minimal change in the firm's valuation assessment. While the ...

How Recent Moves Are Rewriting the Story for Oracle’s AI and Cloud Future

Oracle's stock price target remains unchanged at $344.04 per share, even though the discount rate increased slightly from ...
TipRanks on MSN

NVDA, TSLA, PLTR: Investor Margin Debt Has Risen 40% Since April Lows

Margin loans taken out by investors to buy high-flying stocks such as Nvidia (NVDA), Tesla (TSLA) and Palantir (PLTR) have ...

History Says Buying Target Stock at a 5% Dividend Yield Is a Good Move. But Is It?

As of this writing, the dividend yield for Target stock is quite high at 4.9%. This means that for every $100 invested in ...

CII: Options Fund With 7% Income, Decent Growth, Zero Leverage, And Lower Volatility

Explore BlackRock Enhanced Large Cap Core Fund, Inc's income-focused, low-volatility S&P 500 strategy. Click for why CII is ...

Margin Debt Continued To Climb To New Heights In October

Margin debt continued to climb to new heights in October, reaching a new all-time high of $1.18 trillion. Read more here.